Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 19 - Hybrid peptides
Patents for C07K 19 - Hybrid peptides (29,428)
05/2003
05/08/2003WO1999009179A3 Antigen constructs useful in the detection and differentiation of antibodies to hiv
05/08/2003US20030088890 Novel ecdysone receptors and methods for their use
05/08/2003US20030087412 Nucleotide sequences coding polypeptide for use in the prevention and treatment of tumors, nervous system, cardiomyopathy, viral and metabolic diseases
05/08/2003US20030087384 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment fibroblast growth factor receptor defects
05/08/2003US20030086919 Targeted killing of a cell utilizing a chimeric polypeptide comprising a cell-specific targeting moiety and a signal transduction pathway factor
05/08/2003US20030086918 For specific cleavage and purification of poly amino acids that have low solubilities
05/08/2003CA2465367A1 Diagnosis and treatment of infectious diseases through indel-differentiated proteins
05/07/2003EP1308462A1 Hepatitis b virus (hbv) antigenic polypeptide-heat shock protein complex and use thereof
05/07/2003EP1307567A2 Regulation of human phosphatidylinositol-specific phospholipase c-like enzyme
05/07/2003EP1307566A2 Mitogen activated kinase
05/07/2003EP1307564A2 Compounds and methods for treatment and diagnosis of chlamydial infection
05/07/2003EP1307554A2 C3b/c4b complement receptor-like molecules and uses thereof
05/07/2003EP1307552A2 C3b/C4b COMPLEMENT RECEPTOR-LIKE MOLECULES AND USES THEREOF
05/07/2003EP1307483A2 Iapl-3 a protein inhibitor of apoptosis proteins
05/07/2003EP1307482A2 Two coloured fluorimetric protease assay
05/07/2003EP1307216A1 Polymer-modified bioactive synthetic chemokines, and methods for their manufacture and use
05/07/2003EP0669982B1 Materials comprising and methods of preparation and use for ribosome-inactivating proteins
05/07/2003CN1416467A Zinc finger domains and methods of identifying same
05/07/2003CN1107681C Compound of polypeptide as antigen of hepatitis B virus and heat shock protein and its application
05/06/2003US6559282 Induction of antibodies against leutenizing hormone releasing hormone in mammals; obtain mammal, administer modulator, monitor immune response, evaluate for prevention of infections
05/06/2003US6559280 Controlling protein levels in eucaryotic organisms
05/06/2003US6558661 Inhibiting binding of interferon-gamma to its native receptor
05/06/2003CA2082160C Humanised and chimeric monoclonal antibodies
05/06/2003CA2018676C Novel heteropolymeric protein production methods
05/02/2003EP1305434A2 A human disintegrin protein
05/02/2003EP1305417A2 Siglec (sialic acid-binding ig-related lectin) polypeptides and uses thereof
05/02/2003EP1305416A2 Identification of a novel glutamine transporter
05/02/2003EP1305415A1 Protein inhibitor of apoptosis proteins
05/02/2003EP1305342A2 Human kininogen d5 domain polypeptides and their use
05/02/2003EP1305340A2 Sequences for integrin alpha-8
05/02/2003EP0674710B1 Peptides with broad neoplastic specificity
05/01/2003WO2003035891A2 Method for formulating and immobilizing a protein matrix and a protein matrix for use in a sensor
05/01/2003WO2003035884A2 Transient immortalization
05/01/2003WO2003035847A2 Il-13 mutein proteins, antibodies, compositions, methods and uses
05/01/2003WO2003035697A1 Fusion peptide of human parathyroid hormone derived peptide and tat peptide, preparation thereof, and skin slimming cosmetic composition comprising the same
05/01/2003WO2003035687A1 Nogo receptor homologues and their use
05/01/2003WO2003035676A1 Groel chimeric protein and vaccine
05/01/2003WO2003034984A2 Compositions and methods for the diagnosis and treatment of inflammatory bowel disorders
05/01/2003WO2002090553A3 Recombinant fusion proteins and the trimers thereof
05/01/2003WO2002083712A3 Transporters and ion channels
05/01/2003WO2002074806A3 New interferon beta-like molecules
05/01/2003WO2002038600A3 C. elegans genes involved in viability and/or reproduction and uses thereof
05/01/2003WO2001079291A3 Secreted proteins
05/01/2003WO2000071564A3 Isolated nucleic acids of the p-hyde family, p-hyde proteins, and methods of inducing susceptibility to induction of cell death in cancer
05/01/2003US20030084463 Method for the production of a protein
05/01/2003US20030083472 Cell surface molecule mediating cell adhesion and signal transmission
05/01/2003US20030083467 Fusion proteins for use in the treatment of tumors and nervous sytem disorders
05/01/2003US20030083253 Polynucleotide encoding autoantigens associated with endometriosis
05/01/2003US20030082747 Fusion polypeptides of human serum albumin and a therapeutically active polypeptide
05/01/2003US20030082643 Human monoclonal antibodies to FC alpha receptor (CD89)
05/01/2003US20030082612 Detection of mutant leptin receptor; obtain cells, extract nucleotide sequences, incubate with an oligonucleotide probe, detect hybridization, presence of hybridization, indicates defective receptor
05/01/2003US20030082198 Administering complex of heat shock protein and antigen
05/01/2003US20030082197 Administering complex of heat shock protein and antigen
05/01/2003US20030082190 Fusion molecules and treatment of IgE-mediated allergic diseases
05/01/2003US20030082176 Therapy for metabolism disorders
05/01/2003US20030082175 April receptor (BCMA) and uses thereof
05/01/2003CA2842429A1 Compositions and methods for the diagnosis and treatment of inflammatory bowel disorders
05/01/2003CA2675409A1 Compositions and methods for the diagnosis and treatment of inflammatory bowel disorders
05/01/2003CA2464695A1 Il-13 mutein proteins, antibodies, compositions, methods and uses
05/01/2003CA2463960A1 Transient immortalization
05/01/2003CA2461665A1 Compositions and methods for the diagnosis and treatment of inflammatory bowel disorders
05/01/2003CA2457545A1 Method for formulating and immobilizing a protein matrix and a protein matrix for use in a sensor
04/2003
04/30/2003CN1415019A Method for making insulin precursors and insulin precursor analogus having improved fermentation yield in yeast
04/30/2003CN1414976A Chimeric peptides used as immunogen and its antibody, and method for their use for immunization
04/30/2003CN1414970A Transgenically produced fusion proteins
04/30/2003CN1107115C System for expression of heterologous antigens as fusion proteins
04/30/2003CN1106858C Vaccine composition having antitumour activity and use there of in therapy of malignant diseases
04/29/2003US6555313 Production of anti-self antibodies from antibody segment repertoires and displayed on phage
04/29/2003CA2258502C Modified factor viii
04/29/2003CA2102208C Binding domains in notch and delta proteins
04/24/2003WO2003034275A2 Chimeric glycosylphosphatidylinositol containing peptides
04/24/2003WO2003033677A2 Dimerized growth factor and materials and methods for producing it
04/24/2003WO2003033654A2 Direct targeting binding proteins
04/24/2003WO2003033653A2 Affinity enhancement agents
04/24/2003WO2003033021A1 Use of peptide vectors to improve the immune response to antigens
04/24/2003WO2003032913A2 Methods and compositions for targeting proteins across the blood brain barrier
04/24/2003WO2003032898A2 Modified human thymic stromal lymphopoietin
04/24/2003WO2003032814A2 Antibodies that bind to cancer-associated antigen cd46 and methods of use thereof
04/24/2003WO2003032813A2 Methods for the treatment of carcinoma
04/24/2003WO2003032727A1 Methods and compositions for targeting underglycosylated proteins across the blood brain barrier
04/24/2003WO2002088180A3 Use of alpha 1-antichymotrypsin for the manufacture of a composition for treatment, prevention or diagnosis of poorly healing diabetic or arterial wounds
04/24/2003WO2002079397A3 Virus derived antimicrobial peptides
04/24/2003WO2002066507A3 Histidine phosphatase interacting protein of 120 kd
04/24/2003WO2002052029A9 Process for producing recombinant protein and fused protein
04/24/2003WO2002046227A3 Glp-1 fusion proteins
04/24/2003US20030078398 Recombinant DNA molecules encoding aminopeptidase enzymes and their use in the preparation of vaccines against helminth infections
04/24/2003US20030078389 Gamma-heregulin
04/24/2003US20030077831 Nucleotide sequences for use as efficient gene transfer and cloning tool in genetic engineering
04/24/2003US20030077826 Chimeric molecules containing a module able to target specific cells and a module regulating the apoptogenic function of the permeability transition pore complex (PTPC)
04/24/2003US20030077772 Method for formulating and immobilizing a protein matrix and a protein matrix for use in a sensor
04/24/2003US20030077706 Mouse cytokine receptor
04/24/2003US20030077705 Nucleotide sequences coding polypeptide for use in the treatment of inflammation and ischemia-reperfusion injury
04/24/2003US20030077246 TNFr/OPG-like molecules and uses thereof
04/24/2003CA2494706A1 Chimeric glycosylphosphatidylinositol containing peptides
04/24/2003CA2463927A1 Antibodies that bind to cancer-associated antigen cd46 and methods of use thereof
04/24/2003CA2463672A1 Direct targeting binding proteins
04/24/2003CA2463492A1 Methods for the treatment of carcinoma
04/24/2003CA2463473A1 Targeted therapeutic proteins
04/24/2003CA2463003A1 Dimerized growth factor and materials and methods for producing it
04/24/2003CA2461575A1 Use of peptide vectors to improve the immune response to antigens
1 ... 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 ... 295